PPAR Agonist Rosiglitazone Suppresses Renal mPGES-1/PGE2 Pathway in db/db Mice
Figure 7
Evaluation of glomerular injury by PAS staining in db/db mice following Rosi treatment. (a) PAS staining. (b) Glomerular injury score. for each group. Data are mean ± SE.
